BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 26353774)

  • 1. Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis.
    Forte D; Ciciarello M; Valerii MC; De Fazio L; Cavazza E; Giordano R; Parazzi V; Lazzari L; Laureti S; Rizzello F; Cavo M; Curti A; Lemoli RM; Spisni E; Catani L
    Stem Cell Res Ther; 2015 Sep; 6(1):170. PubMed ID: 26353774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous vs intraperitoneal mesenchymal stem cells administration: what is the best route for treating experimental colitis?
    Gonçalves Fda C; Schneider N; Pinto FO; Meyer FS; Visioli F; Pfaffenseller B; Lopez PL; Passos EP; Cirne-Lima EO; Meurer L; Paz AH
    World J Gastroenterol; 2014 Dec; 20(48):18228-39. PubMed ID: 25561790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of unlicensed bone marrow-derived platelet lysate-expanded mesenchymal stromal cells in colitis: a pre-clinical study.
    Salmenkari H; Laitinen A; Forsgård RA; Holappa M; Lindén J; Pasanen L; Korhonen M; Korpela R; Nystedt J
    Cytotherapy; 2019 Feb; 21(2):175-188. PubMed ID: 30611671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Potential of Secreted Molecules Derived from Human Amniotic Fluid Mesenchymal Stem/Stroma Cells in a Mice Model of Colitis.
    Legaki E; Roubelakis MG; Theodoropoulos GE; Lazaris A; Kollia A; Karamanolis G; Marinos E; Gazouli M
    Stem Cell Rev Rep; 2016 Oct; 12(5):604-612. PubMed ID: 27503204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraluminal Injection of Mesenchymal Stromal Cells in Spheroids Attenuates Experimental Colitis.
    Molendijk I; Barnhoorn MC; de Jonge-Muller ES; Mieremet-Ooms MA; van der Reijden JJ; van der Helm D; Hommes DW; van der Meulen-de Jong AE; Verspaget HW
    J Crohns Colitis; 2016 Aug; 10(8):953-64. PubMed ID: 26896084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic Administration of Mesenchymal Stromal Cells Reduces Inflammation in Experimental Colitis.
    Barnhoorn M; de Jonge-Muller E; Molendijk I; van Gulijk M; Lebbink O; Janson S; Schoonderwoerd M; van der Helm D; van der Meulen-de Jong A; Hawinkels L; Verspaget H
    Inflamm Bowel Dis; 2018 Jul; 24(8):1755-1767. PubMed ID: 29796655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine.
    Sala E; Genua M; Petti L; Anselmo A; Arena V; Cibella J; Zanotti L; D'Alessio S; Scaldaferri F; Luca G; Arato I; Calafiore R; Sgambato A; Rutella S; Locati M; Danese S; Vetrano S
    Gastroenterology; 2015 Jul; 149(1):163-176.e20. PubMed ID: 25790743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study the effects of mesenchymal stem cell conditioned medium injection in mouse model of acute colitis.
    Pouya S; Heidari M; Baghaei K; Asadzadeh Aghdaei H; Moradi A; Namaki S; Zali MR; Hashemi SM
    Int Immunopharmacol; 2018 Jan; 54():86-94. PubMed ID: 29112894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early injection of human adipose tissue-derived mesenchymal stem cell after inflammation ameliorates dextran sulfate sodium-induced colitis in mice through the induction of M2 macrophages and regulatory T cells.
    Kawata Y; Tsuchiya A; Seino S; Watanabe Y; Kojima Y; Ikarashi S; Tominaga K; Yokoyama J; Yamagiwa S; Terai S
    Cell Tissue Res; 2019 May; 376(2):257-271. PubMed ID: 30635774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis.
    Liang L; Dong C; Chen X; Fang Z; Xu J; Liu M; Zhang X; Gu DS; Wang D; Du W; Zhu D; Han ZC
    Cell Transplant; 2011; 20(9):1395-408. PubMed ID: 21396175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.
    Stavely R; Robinson AM; Miller S; Boyd R; Sakkal S; Nurgali K
    Stem Cell Res Ther; 2015 Dec; 6():263. PubMed ID: 26718461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Xie M; Qin H; Luo Q; He X; He X; Lan P; Lian L
    Dig Dis Sci; 2017 Jan; 62(1):115-123. PubMed ID: 27107864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intercellular adhesion molecule-1 enhances the therapeutic effects of MSCs in a dextran sulfate sodium-induced colitis models by promoting MSCs homing to murine colons and spleens.
    Li X; Wang Q; Ding L; Wang YX; Zhao ZD; Mao N; Wu CT; Wang H; Zhu H; Ning SB
    Stem Cell Res Ther; 2019 Aug; 10(1):267. PubMed ID: 31443680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 3 pre-conditioning increases the therapeutic efficacy of umbilical cord mesenchymal stromal cells in a dextran sulfate sodium-induced colitis model.
    Fuenzalida P; Kurte M; Fernández-O'ryan C; Ibañez C; Gauthier-Abeliuk M; Vega-Letter AM; Gonzalez P; Irarrázabal C; Quezada N; Figueroa F; Carrión F
    Cytotherapy; 2016 May; 18(5):630-41. PubMed ID: 27059200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice.
    Wang WQ; Dong K; Zhou L; Jiao GH; Zhu CZ; Li WW; Yu G; Wu WT; Chen S; Sun ZN; Wang YM; Liu WT; Zhang J; Wang BM; Feng XM
    Acta Pharmacol Sin; 2015 Nov; 36(11):1377-87. PubMed ID: 26190499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.
    Nam YS; Kim N; Im KI; Lim JY; Lee ES; Cho SG
    World J Gastroenterol; 2015 Feb; 21(7):2030-9. PubMed ID: 25717235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cell therapy for Crohn's disease.
    Liew A; O'Brien T; Egan L
    Dig Dis; 2014; 32 Suppl 1():50-60. PubMed ID: 25531353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis.
    Li L; Liu S; Xu Y; Zhang A; Jiang J; Tan W; Xing J; Feng G; Liu H; Huo F; Tang Q; Gu Z
    Pharmacology; 2013; 92(5-6):257-64. PubMed ID: 24280970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.